特定患者中非计划性撤除连续流左心室辅助装置的结果
该单中心回顾性分析纳入2002至2021年61例撤除连续流左心室辅助装置的患者,其中21例因装置感染、血栓、故障或脑出血行非计划性撤除,5年生存率81.3%(95%CI 63.8-1)。结论认为非计划性撤除在特定患者中可行,但撤除前评估需进一步研究。
要点
- 61例撤除连续流左心室辅助装置患者中,40例按方案计划性撤除,21例非计划性撤除。
- 非计划性撤除原因为装置感染12例、装置血栓6例、装置故障2例、急性脑出血1例。
- 非计划性撤除组5年生存率81.3%(95%CI 63.8-1),部分患者不符合既定撤除标准。
核心结论
- 在经验丰富的心脏外科医生、心脏科医生、技术人员和心室辅助装置协调员团队讨论后,特定患者中非计划性撤除是可能的。
- 连续流左心室辅助装置撤除或停用前的适当术前评估需要进一步研究。
研究设计与样本
- 回顾性分析2002年至2021年单中心所有接受左心室辅助装置撤除或停用的患者。
主要发现
- 61例患者撤除连续流左心室辅助装置,包括HeartMate II 17例、HeartMate 3 2例、HeartWare HVAD 36例、INCOR 6例。
- 撤除后中位随访1039天,5年生存率为76.1%(95%CI 64.2%-95.2%)。
- 单因素回归分析中,结局较差的预测因素为心力衰竭持续时间和左心室辅助装置植入时年龄。
- 40例按特定方案计划性撤除,21例非计划性撤除,后者5年生存率为81.3%(95%CI 63.8-1)。
- 非计划性撤除患者中,未符合成功撤除或停用既定标准的情况包括临床稳定性21例、左心室舒张末期内径≤55 mm 3例、右心导管检查6例、肺动脉楔压≤15 mm Hg 3例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Protocols have been developed to identify patients for elective withdrawal of continuous-flow left ventricular device (cfLVAD) support. However, little is known about non-elective explantation or decommissioning of cfLVADs. METHODS: A retrospective analysis of all patients who underwent left ventricular assist device (LVAD) explantation or decommissioning at a single center between 2002 and 2021 was performed. RESULTS: Sixty-one patients underwent withdrawal of a cfLVAD (HeartMate II [Abbott] n = 17, HeartMate 3 [Abbott] n = 2, HeartWare HVAD [Medtronic] n = 36, INCOR [Berlin Heart] n = 6). The median follow-up after withdrawal was 1,039 days. The survival at 5 years was 76.1% (95% CI: 64.2%-95.2%). Predictors of worse outcomes in univariate regressive analysis were the duration of heart failure and the age at LVAD implantation. Of the 61 patients, 40 underwent elective withdrawal following a specific protocol. The other twenty-one patients underwent non-elective withdrawal of the cfLVAD because of device infection (n = 12), device thrombosis (n = 6), device malfunction (n = 2) or due to acute intracerebral bleeding (n = 1), also with an excellent survival at 5 years of 81.3%. (95% CI: 63.8-1). The withdrawal was performed in these patients even though they did not fulfill established criteria for successful explantation or decommissioning like clinical stability (n = 21), left ventricular end-diastolic diameter ≤ 55 mm (n = 3), performance of right heart catheterization (n = 6), or pulmonary artery wedge pressure ≤ 15 mm Hg (n = 3). CONCLUSION: Non-elective withdrawal is possible in selected patients after discussion in a team of experienced cardiac surgeons, cardiologists, technicians, and VAD coordinators. The appropriate preoperative assessment before decommissioning or explantation of a cfLVAD warrants further investigation.
引用
- Knierim J, Tsyganenko D, Stein J, et al. Results of non-elective withdrawal of continuous-flow left ventricular assist devices in selected patients. J Heart Lung Transplant. 2022. PMID: 36529649. doi:10.1016/j.healun.2022.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。